Drug Topics - November 19, 2007 - (Page 32)

32 DRUG TOPICS NOVEMBER 19, 2007 www.drugtopics.com > > > New Products Rx NEW DRUGS JSJ Pharmaceuticals, Charleston, S.C., (800) 4994468, is introducing Inova 8/2 ACT, an acnecontrol therapy that provides 8% benzoyl peroxide and 2% salicylic acid in an Easy Pad delivery system. The drug, indicated for the management of inflammatory and noninflammatory acne lesions, is available in 3-gm individual foil pouches. NEW FORMULATIONS Voltaren Gel (diclofenac sodium topical gel) 1%, the product of Novartis Consumer Health, Parsippany, N.J., (973) 503-8000, has received the FDA’s nod as the first approved topical prescription treatment for the pain of osteoarthritis. This nonsteroidal antiinflammatory drug can significantly reduce pain in the knees and the joints of the hands, even with 94% less drug absorption throughout the body than with oral diclofenac treatment. ADVERTISERS INDEX BROVANA (Sepracor Inc.) . . . . . . . . . . INSERT CEFOTETAN (Abraxis Pharmaceutical Partners) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . HSE13 CORPORATE (Actavis) . . . . . . . . . . . . . . . . . . . . 35 CORPORATE (Eisai Inc.) . . . . . . . . . . . . . . . . . . . 5 CORPORATE (Emporos Systems) . . . . . . HSE10 CORPORATE (Lexi-Comp) . . . . . . . . . . . . HSE2-3 CORPORATE (Mylan Pharmaceuticals) . . . . . 15 CORPORATE (Thomson) . . . . . . . . . . . . . . . . . . 17 CORPORATE (UnitedHealthcare Group) . . . . . . 7 CORPORATE (University of Pittsburgh) . . . . . 32 DORIPENEM (Ortho-McNeil Pharmaceuticals) . . . . . . . . . . . . . . . . . . . . . HSE15 EARCHECK (Innovia) . . . . . . . . . . . . . . . . . . . . . 31 FAMCICLOVIR (TEVA USA) . . . . . . . . . . . . . . . 11 FLECTOR PATCH (Alpharma) . . . . . . . . . . IFC-1 FREESTYLE (Abbott Laboratories) . . . . . . . . . . 19 GLUCAGEN HYPOKIT (Novo Nordisk) IBC-BC INVEGA (Janssen Pharmaceutica) . . . . HSE6-9 LANTUS (Aventis Pharmaceuticals) . . INSERT METRONIDAZOLE (Fougera) . . . . . . . . . . . . . . 3 TAMPALERT (EPS Inc.) . . . . . . . . . . . . . . HSE24 TARCEVA (Genentech) . . . . . . . . . . . . . . INSERT THROMBIN (King Pharmaceuticals) HSE20-22 TYGACIL (WyethPharmaceuticals) . HSE17-18 IFC-Inside front cover IBC-Inside back cover BC-Back cover NEW LABELING The FDA has approved changes in storage conditions for Humate-P, a protein that helps stop bleeding in certain adult patients with hemophilia A or adult or pediatric patients with von Willebrand disease. Humate-P can now be stored for up to two years at 77oF. The drug is the product of CSL Behring, King of Prussia, Pa., (610) 878-4000. Sanofi-pasteur, Swiftwater, Pa., (570) 839-7187, is the manufacturer of Menactra, a bacterial meningitis vaccine approved in 2005 for patients ages 11 to 55 years. The vaccine can now be used for children aged two to 10. Expanded labeling has been approved for Merck & Co.’s Januvia (sitagliptin), initially indicated as an adjunct to diet and exercise for the treatment of Type 2 diabetes. New labeling recommends, in addition to diet and exercise, initial therapy in combination with metformin; add-on therapy to a sulfonylurea when a single agent does not provide adequate glycemic control; and add-on therapy to a sulfonylurea/metformin combination when dual therapy does not provide adequate glycemic control. Also included are postmarketing reports of hypersensitivity reactions that include anaphylaxis, angioedema, and exfoliative skin conditions, including Stevens-Johnson syndrome. Merck is in Whitehouse Station, N.J., at (908) 423-1000. DT http://www.drugtopics.com http://www.pharmacy.pitt.edu/dmeducatece http://www.pharmacy.pitt.edu/dmeducatece http://www.pharmacy.pitt.edu/dmeducatece

Table of Contents Feed for the Digital Edition of Drug Topics - November 19, 2007

Drug Topics - November 19, 2007 Contents Latebreakers Letters Leukemia Patients Now Have More Options First-in-Class HIV Drug Boon to Patients at End of Tether 150 Years of American Pharmacy Pharmacy Schools Confront New Pressures From Pariah to Patient ACCP Releases Position Paper on Ethical Interactions New Injectable Antibiotic Welcomed with Open Arms NCCN Updates Head and Neck Cancer Guide Improved Phosphate Binder Approved for Dialysis Patients Considering Combination Concern Ensuring Seamless Care Bill Would Create Center for Comparative Effectiveness Hospital Improves Patient Safety with Automatic Drug Distribution System Infection Rates, Patient Stays Drop with New Drug Device How R.Ph.s Helped Three Hospitals Win Quality and Safety Awards A Pharmacist and Dog in Tow are Alzheimer’s Patients’ Best Friends More PBMs Agreeing to Pricing Transparency New Insulins in the Management of Diabetes New Products Advertisers Index Classified VIEWPOINT: Reflections on Pharmacy School After 30 Years

Drug Topics - November 19, 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.